LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve Vision

SEATTLE--(BUSINESS WIRE)-- #DryAMD--LumiThera, Inc. today announced the U.S. FDA has authorized marketing of Valeda® Light Delivery System for patients with dry AMD.